Crossmark

GlucoCEST MRI for the Evaluation Response to Chemotherapeutic and Metabolic Treatments in a Murine Triple-Negative Breast Cancer: A Comparison with[18F]F-FDG-PET

Crossref DOI link: https://doi.org/10.1007/s11307-021-01637-6

Published Online: 2021-08-12

Published Print: 2022-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Capozza, Martina

Anemone, Annasofia

Dhakan, Chetan

Della Peruta, Melania

Bracesco, Martina

Zullino, Sara

Villano, Daisy

Terreno, Enzo

Longo, Dario Livio https://orcid.org/0000-0002-6906-9925
Aime, Silvio
Funding

Funding for this research was provided by:

Horizon 2020 (6677510)

Associazione Italiana per la Ricerca sul Cancro (ID 24104)

associazione italiana per la ricerca sul cancro (MFAG ID 20153)
License Information

Text and Data Mining valid from 2021-08-12

Version of Record valid from 2021-08-12
More Information

Article History

Received: 9 March 2021

Revised: 30 June 2021

Accepted: 28 July 2021

First Online: 12 August 2021

Declarations

:

: The authors declare that they have no conflict of interest.

Document is current

Any future updates will be listed below